François Bertucci

33.0k citations

515 papers · 18.8k indexed · 5 hit papers · h-index 72

Impact in

Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 0.1%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research

Papers in

Cancer Research 149
- Breast Cancer Treatment Studies 74
- Cancer Genomics and Diagnostics 61
Gastroenterology 52
- Gastrointestinal Tumor Research and Treatment 52

Co-authors: Daniel Birnbaum Pascal Finetti Patrice Viens Emmanuelle Charafe‐Jauffret Jocelyne Jacquemier Nathalie Cervera Anthony Gonçalvès José Adélaı̈de
Journals: Journal of Clinical Oncology (62 papers)Annals of Oncology (43 papers)Cancer Research (22 papers)Cancers (20 papers)European Journal of Cancer (18 papers)
Partner nations: France United States Belgium

In The Last Decade

François Bertucci

499 papers receiving 18.5k citations

Hit Papers

5 papers align trajectories log scale

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer 2022 · 202 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Cell Research
2020 Cell Metabolism
2011 Journal of Clinical Investigation
2009 Cancer Research
2009 Clinical Cancer Research

Peers

Countries citing papers authored by François Bertucci

Since Specialization

Citations

This map shows the geographic impact of François Bertucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Bertucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Bertucci more than expected).

Fields of papers citing papers by François Bertucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Bertucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Bertucci. The network helps show where François Bertucci may publish in the future.

Co-authorship network

The 25 scholars most cited alongside François Bertucci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with François Bertucci Line = papers co-authored together François Bertucci links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial Annals of Oncology ·Nicolas Penel, Antoîne Italiano, Jennifer Wallet, L. Chaigneau, L. Bratinkova, Nelly Firmin, Sarah Watson, Mariana E Paez, Emmanuelle Bompas, François Bertucci, Mehdi Brahmi, Clémence Henon, Angélique Brunot, Mariella Spalato Ceruso, Gbor Nagy, Esra Ergün, Thomas Ryckewaert, Marie‐Cécile Le Deley, Christophe Perrin, Jean‐Yves Blay	2025	0
2	1718O EREMISS trial: A double-blind placebo (PBO)-controlled randomised trial assessing efficacy/safety of regorafenib (REGO) as maintenance therapy after 1st line doxorubicin-based chemotherapy in advanced soft-tissue sarcoma (ASTS) patients (pts) Annals of Oncology ·전현희, Silva José Aparecido da, Jennifer Wallet, L. Chaigneau, Bharat Karnad, Nelly Firmin, Sarah Watson, Thomas Valentin, Emmanuelle Bompas, François Bertucci, Віталій Володимирович Лукічов, A. Le Cesne, Angélique Brunot, Mariella Spalato Ceruso, Gbor Nagy, Костылева Светлана Юрьевна, S. Taïeb, M. Le Deley, Christophe Perrin, Jean‐Yves Blay	2024	1
3	Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study ESMO Open ·Axel Le Cesne, Christine Chevreau, Christophe Perrin, Antoîne Italiano, Alice Hervieu, Jean‐Yves Blay, Sophie Piperno‐Neumann, Esma Saâda-Bouzid, François Bertucci, Nelly Firmin, Elsa Kalbacher, Christoph Hardt, Camille Schiffler, 广东省总工会, Marta Jimenez, Corinne Bouvier, Vincent Vidal, Sylvie Chabaud, Florence Duffaud	2023	9
4	The serine/threonine kinase MINK1 directly regulates the function of promigratory proteins Journal of Cell Science ·Avais M. Daulat, Suresh M Padaliya, Stéphane Audebert, Małgorzata Kowalczewska, Bernhard U. Koelle, Pascal Finetti, François Bertucci, Luc Camoin, Jean‐Paul Borg	2022	6
5	Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma Clinical Cancer Research ·David Jérémie Birnbaum, Beata Świątek, Pascal Finetti, Charles Vanderburg, Anupriya S. Kulkarni, Azfar Neyaz, Thomas Hank, Eric C. Tai, Vikram Deshpande, François Bertucci, Daniel Birnbaum, Keith D. Lillemoe, Andrew L. Warshaw, Mari Mino–Kenudson, Carlos Fernández‐del Castillo, David T. Ting, Andrew S. Liss	2021	11
6	Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy Cancers ·Gayathri R. Devi, Pascal Finetti, Michael A. Morse, Sonika Chopra, Alexandre de Nonneville, Steven Van Laere, Jesse D. Troy, Joseph Geradts, Shannon J. McCall, François Bertucci	2021	22
7	Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer Clinical Cancer Research ·François Richard, Samira Majjaj, David Venet, Françoise Rothé, Michael Reiss, Bram Boeckx, Caterina Marchiò, Florian Clatot, François Bertucci, Odette Mariani, Christine Galant, Gert Van den Eynden, Roberto Salgado, Elia Biganzoli, Diether Lambrechts, Anne Vincent‐Salomon, Giancarlo Pruneri, Denis Larsimont, Christos Sotiriou, Christine Desmedt	2020	19
8	Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer Clinical Cancer Research ·Yi Xiao, Ding Ma, Shen Zhao, Chen Suo, Jinxiu Shi, Mengzhu Xue, Miao Ruan, Hai Wang, Jingjing Zhao, Qin Li, Peng Wang, Leming Shi, Wentao Yang, Wei Huang, Xin Hu, Ke‐Da Yu, Shenglin Huang, François Bertucci, Yi‐Zhou Jiang, Zhi-Ming Shao	2019	265
9	Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial The Lancet Oncology ·Axel Le Cesne, Jean‐Yves Blay, Julien Dômont, Emmanuelle Tresch‐Bruneel, Christine Chevreau, François Bertucci, Corinne Delcambre, Esma Saâda-Bouzid, Sophie Piperno‐Neumann, Jacques‐Olivier Bay, Olivier Mir, Isabelle Ray‐Coquard, Thomas Ryckewaert, Thibaud Valentin, Nicolás Isambert, Antoîne Italiano, Stéphanie Clisant, Nicolas Penel	2015	63
10	EFA6B Antagonizes Breast Cancer Cancer Research ·Joséphine Zangari, Mariagrazia Partisani, François Bertucci, Julie Milanini, Ghislain Bidaut, Carole Berruyer-Pouyet, Pascal Finetti, Élodie Long-Mira, Frédéric Brau, Olivier Cabaud, Bruno Chetaille, Daniel Birnbaum, Marc Lopez, Paul Hofman, Michel Franco, Frédéric Luton	2014	21
11	The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression Clinical Cancer Research ·Haojie Zhao, Julien Wicinski, Olivier Cabaud, Yves Toiron, Pascal Finetti, Emmanuelle Josselin, Hélène Lelièvre, Laurence Kraus‐Berthier, Stéphane Depil, François Bertucci, Yves Collette, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Christophe Ginestier	2013	113
12	Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02) Clinical Cancer Research ·Juliette Thariat, René‐Jean Bensadoun, Marie-Christine Étienne-Grimaldi, Dominique Grall, Frédérique Penault‐Llorca, O. Dassonville, François Bertucci, Anne Cayre, D. De Raucourt, Lionnel Geoffrois, Pascal Finetti, P. Giraud, S. Racadot, S. Morinière, Anne Sudaka, Ellen Van Obberghen‐Schilling, G. Milano	2012	26
13	Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition Cancer Research ·Émilie Mamessier, Aude Sylvain, François Bertucci, Rémy Castellano, Pascal Finetti, Gilles Houvenaeghel, Yavuz Bozkurt, Daniel Birnbaum, Alessandro Moretta, D Olive	2011	100
14	Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer Clinical Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino, Carole Tarpin, Mark E. Diebel, Benjamin Esterni, Gilles Houvenaeghel, Karen Higginbotham, François Bertucci, Jocelyne Jacquemier, Luc Xerri, Gabriela Dontu, Giorgio Stassi, Yi Xiao, Sanford H. Barsky, Daniel Birnbaum, Patrice Viens, Max S. Wicha Hit paper breakdown →	2009	575
15	Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino, Julien Wicinski, Nathalie Cervera, Pascal Finetti, Min-Hee Hur, Mark E. Diebel, Florence Monville, Julie Dutcher, Marty Brown, Patrice Viens, Luc Xerri, François Bertucci, Giorgio Stassi, Gabriela Dontu, Daniel Birnbaum, Max S. Wicha Hit paper breakdown →	2009	935
16	Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis Cancer Research ·Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, Christian Chabannon, Colette Charpin, Max Chaffanet, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum, François Bertucci	2008	96
17	Integrated Profiling of Basal and Luminal Breast Cancers Cancer Research ·José Adélaı̈de, Pascal Finetti, Ismahane Bekhouche, James Bruce Nixon, Jeannine Geneix, Fabrice Sircoulomb, Emmanuelle Charafe‐Jauffret, Nathalie Cervera, Jérôme Desplans, Daniel Parzy, Eric Schoenmakers, Patrice Viens, J Jacquemier, Daniel Birnbaum, François Bertucci, Max Chaffanet	2007	221
18	Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers Cancer Research ·François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, Émilie Mamessier, José Adélaı̈de, Stéphane Debono, Gilles Houvenaeghel, D Maraninchi, Patrice Viens, Colette Charpin, Jocelyne Jacquemier, Daniel Birnbaum	2006	218
19	Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers Clinical Cancer Research ·Christophe Ginestier, Nathalie Cervera, Pascal Finetti, Séverine Esteyriès, Benjamin Esterni, José Adélaı̈de, Luc Xerri, Patrice Viens, Jocelyne Jacquemier, Emmanuelle Charafe‐Jauffret, Max Chaffanet, Daniel Birnbaum, François Bertucci	2006	107
20	Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis Cancer Research ·Jocelyne Jacquemier, Christophe Ginestier, Jacques Rougemont, Valérie‐Jeanne Bardou, Emmanuelle Charafe‐Jauffret, Jeannine Geneix, José Adélaı̈de, Alane Koki, Gilles Houvenaeghel, J Hassoun, D Maraninchi, Patrice Viens, Daniel Birnbaum, François Bertucci	2005	174

About François Bertucci

François Bertucci is a scholar working on Cancer Research, Gastroenterology, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 515 papers that have together received 18.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (132 papers), Breast Cancer Treatment Studies (74 papers), Cancer Genomics and Diagnostics (61 papers), Gastrointestinal Tumor Research and Treatment (52 papers), HER2/EGFR in Cancer Research (47 papers), Gene expression and cancer classification (47 papers), Cancer Cells and Metastasis (45 papers) and Lymphoma Diagnosis and Treatment (36 papers). The work is most often cited by research in Cancer Research (5.4k citations), Oncology (8.9k citations), Gastroenterology (965 citations), Pulmonary and Respiratory Medicine (4.8k citations) and Immunology (2.7k citations). François Bertucci has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Daniel Birnbaum, Pascal Finetti, Patrice Viens, Emmanuelle Charafe‐Jauffret, Jocelyne Jacquemier, Nathalie Cervera, Anthony Gonçalvès, José Adélaı̈de, Christophe Ginestier and Émilie Mamessier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancers and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact